Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
Sphingosine has been shown to prevent and eliminate bacterial infections of the respiratory tract, but it is unknown whether sphingosine can be also employed to prevent viral infections. To test this hypothesis